Who can receive funded Zostavax®?
- Adults aged 65 years
Catch-up programme EXTENDED TO 31 December 2021
- Adults aged 66–80 years
Zostavax and annual influenza vaccination
- Annual influenza immunisation is recommended and funded for adults aged 65 years or over.
- One Zostavax is recommended for adults aged 65 years to under 81 years. This dose is also funded.
- Zostavax and influenza vaccine can be administered at the same visit.
- Zostavax is only given as a single dose – it IS NOT administered every year that an eligible adult receives their influenza vaccination.
- When Zostavax and an influenza vaccination are administered to an eligible adult at the same visit from 1 April through 31 December:
- The ability to claim an additional payment of $15 for administering Zostavax and influenza vaccines at the same visit that was introduced from 4 June 2018 will continue in 2019. Please contact your PHO on how to claim for these events.
Hormonal cancer treatments and Zostavax
The following hormonal cancer treatments do not cause immunosuppression:
Trade – Generic name
Generic – Trade name
|Arimidex – Anastrazole||Anastrazole – Arimidex|
|Bicalox – Bicalutamide||Bicalutamide – Bicalox|
|Mestane – Exemestane||Cyproterone – Procur, Siterone|
|Letara – Letrozole||Exemestane – Mestane|
|Letrole – Letrozole||Goserelin – Zolodex|
|Procur – Cyproterone||Letrozole – Letara, Letrole|
|Siterone – Cyproterone||Tamoxifen – Tamoxifen|
|Tamoxifen – Tamoxifen|
|Zolodex – Goserelin|